FIELD: medicine.
SUBSTANCE: method of enzyme immunoassay is used to detect the presence of a complex of serum cytokines - IL-1β, IL-2, IL-6, IL-18, IFNα, IFNγ in the blood taken from the ulnar vein, with the subsequent determination of their levels. At IFNα - from 2.9 to 10.3 pg/ml, IFNγ - from 7.5 to 10.9 pg/ml, IL-1β - from 2.2 to 12.6 pg ml, IL-2 - from 1.7 to 7.5 pg/ml, IL-6 - from 1.4 to 9.4 pg/ml, IL-18 - from 847 to 1353 pg/ml abstinence symptoms with opium addiction combined with HIV infection are diagnosed.
EFFECT: application of this invention allows differential diagnosis of abstinence symptoms associated with opium addiction combined with HIV infection, which determines the necessity to prescribe the necessary etiotropic and pathogenetic therapy early in the course of the disease.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTICS TECHNIQUE FOR ACTIVE OPIUM ADDICTION IN PATIENTS WITH CHRONIC VIRAL HEPATITIS TYPE C | 2010 |
|
RU2417759C1 |
| DIAGNOSTIC TECHNIQUE FOR CHRONIC VIRAL HEPATITIS TYPE C ASSOCIATED WITH OPIUM ADDICTION | 2010 |
|
RU2417370C1 |
| METHOD OF EARLY PREDICTION OF MISCARRIAGE BY ASSESSING INTERLEUKIN 1Β AND PROSTAGLANDIN E2 IN THE BLOOD SERUM OF PREGNANT WOMEN WITH EXACERBATION OF CYTOMEGALOVIRUS INFECTION | 2023 |
|
RU2804278C1 |
| METHOD OF TREATING PAPILLOMA VIRAL INFECTIONS IMPLEMENTED THROUGH INTERLEUKIN-18 INDUCTION | 2010 |
|
RU2482866C2 |
| METHOD OF PREDICTING COMPLICATIONS AFTER COVID-19 IN PERSONS WITH COMORBID BACKGROUND IN THE ARCTIC REGION | 2023 |
|
RU2812780C1 |
| METHOD FOR PREDICTION OF AGGRAVATED BRONCHIAL ASTHMA AND/OR CYSTIC FIBROSIS ACCOMPANYING INFLUENZA IN CHILDREN | 2013 |
|
RU2522276C1 |
| DIAGNOSTIC TECHNIQUE FOR PULMONARY TUBERCULOSIS | 2012 |
|
RU2503005C1 |
| METHOD FOR PREDICTING THE LETHAL OUTCOME IN PATIENTS WITH SEVERE CoVID-19 | 2021 |
|
RU2780748C1 |
| METHOD OF CLINICAL OUTCOME FORECAST OF ACUTE VIRAL HEPATITIS B | 2007 |
|
RU2325656C1 |
| METHOD FOR TREATING OPIUM NARCOMANIA | 2005 |
|
RU2290947C1 |
